McKesson Corp. EVP Paul Julian Sells 84,000 Shares (MCK)
McKesson Corp. (NYSE:MCK) EVP Paul Julian sold 84,000 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $134.04, for a total transaction of $11,259,360.00. Following the completion of the transaction, the executive vice president now directly owns 57 shares in the company, valued at approximately $7,640. The transaction was disclosed in a document filed with the SEC, which is available at this link.
McKesson Corp. (NYSE:MCK) traded up 3.30% during mid-day trading on Thursday, hitting $137.88. 2,285,688 shares of the company’s stock traded hands. McKesson Corp. has a one year low of $89.00 and a one year high of $138.43. The stock has a 50-day moving average of $127. and a 200-day moving average of $117.6. The company has a market cap of $31.523 billion and a P/E ratio of 22.93.
McKesson Corp. (NYSE:MCK) last released its earnings data on Thursday, July 25th. The company reported $2.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.36. The company had revenue of $32.20 billion for the quarter, compared to the consensus estimate of $32.60 billion. During the same quarter in the previous year, the company posted $1.55 earnings per share. The company’s revenue for the quarter was up 4.9% on a year-over-year basis. On average, analysts predict that McKesson Corp. will post $8.32 earnings per share for the current fiscal year.
A number of analysts have recently weighed in on MCK shares. Analysts at Raymond James upgraded shares of McKesson Corp. from a “market perform” rating to an “outperform” rating in a research note to investors on Wednesday. They now have a $155.00 price target on the stock. Separately, analysts at Sterne Agee reiterated a “buy” rating on shares of McKesson Corp. in a research note to investors on Tuesday, October 1st. They now have a $164.00 price target on the stock. Finally, analysts at Robert W. Baird raised their price target on shares of McKesson Corp. from $135.00 to $150.00 in a research note to investors on Tuesday, October 1st. They now have an “outperform” rating on the stock. Two research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $134.00.
McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technologies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.